Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Clinical Research and Equipment Industry Analysis

UpdatedJun 29, 2026
DataAggregated Company Financials
Companies9
  • 7D8.0%
  • 3M18.7%
  • 1Y-12.1%
  • YTDn/a

In the last week, the Clinical Research and Equipment industry is up 8.0%, with AddLife up 9.3%. In the past year, the industry is down 12%. Looking forward, earnings are forecast to grow by 19% annually.

Industry Valuation and Performance

Has the Swedish Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 29 Jun 2026SEK 31.2bSEK 14.6b-SEK 871,304,353.0036.5x-35.8x2.1x
Wed, 27 May 2026SEK 30.0bSEK 14.6b-SEK 849,175,077.0037.6x-35.3x2.1x
Fri, 24 Apr 2026SEK 30.7bSEK 14.6b-SEK 971,664,077.0035.9x-31.6x2.1x
Sun, 22 Mar 2026SEK 26.3bSEK 14.6b-SEK 838,374,077.0031.2x-31.4x1.8x
Tue, 17 Feb 2026SEK 26.8bSEK 14.9b-SEK 553,301,427.0032.6x-48.4x1.8x
Thu, 15 Jan 2026SEK 30.2bSEK 14.9b-SEK 744,515,427.0047.9x-40.5x2x
Sat, 13 Dec 2025SEK 32.9bSEK 14.9b-SEK 744,515,427.0054.5x-44.2x2.2x
Mon, 10 Nov 2025SEK 34.5bSEK 14.7b-SEK 748,598,012.0057.3x-46x2.3x
Wed, 08 Oct 2025SEK 35.4bSEK 14.7bSEK 61.3m58.4x578.3x2.4x
Fri, 05 Sep 2025SEK 34.4bSEK 14.7bSEK 60.9m55.5x565.6x2.3x
Sun, 03 Aug 2025SEK 35.8bSEK 14.8bSEK 158.0m61.3x226.3x2.4x
Tue, 01 Jul 2025SEK 46.5bSEK 16.6bSEK 416.3m68.5x111.7x2.8x
Thu, 29 May 2025SEK 45.6bSEK 16.6bSEK 404.2m72.3x112.9x2.7x
Sat, 26 Apr 2025SEK 43.1bSEK 16.6bSEK 580.4m46.5x74.2x2.6x
Mon, 24 Mar 2025SEK 37.2bSEK 16.6bSEK 614.3m38x60.5x2.2x
Wed, 19 Feb 2025SEK 44.0bSEK 17.0b-SEK 1,033,505,426.0043.3x-42.6x2.6x
Fri, 17 Jan 2025SEK 41.8bSEK 16.7b-SEK 1,152,911,426.0043.4x-36.3x2.5x
Sun, 15 Dec 2024SEK 44.1bSEK 16.7b-SEK 1,152,911,426.0050.4x-38.3x2.6x
Tue, 12 Nov 2024SEK 44.7bSEK 16.8b-SEK 948,072,426.0050.9x-47.1x2.7x
Thu, 10 Oct 2024SEK 47.1bSEK 16.7b-SEK 988,175,491.0058.7x-47.7x2.8x
Sat, 07 Sep 2024SEK 47.4bSEK 16.7b-SEK 988,176,492.0059.9x-48x2.8x
Mon, 05 Aug 2024SEK 47.4bSEK 16.7b-SEK 1,128,120,510.0059.9x-42x2.8x
Wed, 03 Jul 2024SEK 42.1bSEK 16.3b-SEK 1,188,686,510.0054.3x-35.4x2.6x
Fri, 31 May 2024SEK 42.3bSEK 16.3b-SEK 1,188,686,510.0059.5x-35.6x2.6x
Sun, 28 Apr 2024SEK 37.7bSEK 16.2b-SEK 1,246,589,705.0036.2x-30.2x2.3x
Tue, 26 Mar 2024SEK 39.7bSEK 16.0b-SEK 1,122,792,210.0034.7x-35.4x2.5x
Thu, 22 Feb 2024SEK 39.3bSEK 16.2b-SEK 1,117,407,350.0043.4x-35.2x2.4x
Sat, 20 Jan 2024SEK 35.8bSEK 15.5b-SEK 1,393,723,683.0042.9x-25.7x2.3x
Mon, 18 Dec 2023SEK 38.2bSEK 15.5b-SEK 1,393,723,683.0047.6x-27.4x2.5x
Wed, 15 Nov 2023SEK 32.6bSEK 15.4b-SEK 1,256,647,710.0037.7x-25.9x2.1x
Fri, 13 Oct 2023SEK 25.2bSEK 15.1b-SEK 1,134,516,711.0035.7x-22.2x1.7x
Sun, 10 Sep 2023SEK 29.2bSEK 15.1b-SEK 1,133,713,072.0038.8x-25.8x1.9x
Tue, 08 Aug 2023SEK 31.9bSEK 15.1b-SEK 213,871,038.0046.3x-149.2x2.1x
Thu, 06 Jul 2023SEK 36.6bSEK 14.6b-SEK 172,476,038.0039x-212.1x2.5x
Price to Earnings Ratio

-212.1x


Total Market Cap: SEK 36.6bTotal Earnings: -SEK 172,476,038.00Total Revenue: SEK 14.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Clinical Research and Equipment Industry Price to Earnings3Y Average 22.2x202420252026
Current Industry PE
  • Investors are relatively neutral on the Swedish Life Sciences Tools and Services industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 2.4x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Swedish Clinical Research and Equipment compare with similar industries?

SE Market-0.81%
Healthcare3.43%
Life Sciences8.00%
Clinical Research and Equipment8.00%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ALIF B AddLifeSEK 170.008.7%
+SEK 1.7b		-9.9%PE36.5x
MCAP MedCapSEK 513.007.1%
+SEK 513.7m		14.5%PE34.2x
GENO Genovis AB (publ.)SEK 19.467.0%
+SEK 84.6m		-26.6%PE52.9x
IDLDX IDL DiagnosticsSEK 0.420.7%
+SEK 691.1k		-20.0%PS1.8x
MAGLE Magle Chemoswed HoldingSEK 1.011.0%
+SEK 282.0k		-96.1%PS0.1x

Latest News

BICO
SEK 16.08
BICO Group
7D
-2.9%
1Y
-55.2%
Narrative Update • Jun 26

BICO: Long Term Incentive Plan Will Support Future Shareholder Return

Analysts have reduced their price target for BICO Group to SEK 23 from SEK 30, citing updated assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E. What's in the News for BICO Group BICO Group's Annual General Meeting on May 7, 2026 approved the implementation of a share based long term incentive program for 2026 to 2029, directed at the CEO, group management, and key employees.
IDLDX
SEK 0.42
IDL Diagnostics
7D
0.7%
1Y
-20.0%
ALIF B
SEK 170.00
AddLife
7D
8.7%
1Y
-9.9%
ATANA
SEK 0.004
Attana
7D
-20.0%
1Y
-82.6%
MCAP
SEK 513.00
MedCap
7D
7.1%
1Y
14.5%
MAGLE
SEK 1.01
Magle Chemoswed Holding
7D
1.0%
1Y
-96.1%
PRO
SEK 10.30
Promimic
7D
-2.8%
1Y
-42.8%
LEVBIO
SEK 0.28
Level Bio
7D
-2.1%
1Y
-17.4%
GENO
SEK 19.46
Genovis AB (publ.)
7D
7.0%
1Y
-26.6%
Analysis Article • May 01

Genovis AB (publ.) Just Missed Earnings - But Analysts Have Updated Their Models

Genovis AB (publ.) ( STO:GENO ) shareholders are probably feeling a little disappointed, since its shares fell 4.4% to...
PEXA B
SEK 0.23
PExA
7D
-1.7%
1Y
-40.4%